These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35284419)

  • 1. An in Silico Approach to Reveal the Nanodisc Formulation of Doxorubicin.
    Xu D; Chen X; Chen Z; Lv Y; Li Y; Li S; Xu W; Mo Y; Wang X; Chen Z; Chen T; Wang T; Wang Z; Wu M; Wang J
    Front Bioeng Biotechnol; 2022; 10():859255. PubMed ID: 35284419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational analysis by NMR and molecular dynamics of adamantane-doxorubicin prodrugs and their assemblies with β-cyclodextrin: A focus on the design of platforms for controlled drug delivery.
    González-Méndez I; Aguayo-Ortiz R; Sorroza-Martínez K; Solano JD; Porcu P; Rivera E; Dominguez L
    Bioorg Med Chem; 2020 Jul; 28(13):115510. PubMed ID: 32359883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo enhancement of anticancer therapy using bare or chemotherapeutic drug-bearing nanodiamond particles.
    Li Y; Tong Y; Cao R; Tian Z; Yang B; Yang P
    Int J Nanomedicine; 2014; 9():1065-82. PubMed ID: 24591828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Dynamics and In Vitro Studies Elucidating the Tunable Features of Reconfigurable Nanodiscs for Guiding the Optimal Design of Curcumin Formulation.
    Li Y; Xu W; Wang X; Lai R; Qiu X; Zeng Z; Wang Z; Wang J
    Bioengineering (Basel); 2024 Feb; 11(3):. PubMed ID: 38534519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanodiamonds enhance therapeutic efficacy of doxorubicin in treating metastatic hormone-refractory prostate cancer.
    Salaam AD; Hwang PT; Poonawalla A; Green HN; Jun HW; Dean D
    Nanotechnology; 2014 Oct; 25(42):425103. PubMed ID: 25277401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
    Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
    Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
    Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
    Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
    Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M
    ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.
    Gao C; Tang F; Gong G; Zhang J; Hoi MPM; Lee SMY; Wang R
    Nanoscale; 2017 Aug; 9(34):12533-12542. PubMed ID: 28819666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of a multifunctional verapamil-loaded nano-carrier based on a self-assembling PEGylated prodrug.
    Zhao D; Liu N; Shi K; Wang X; Wu G
    Colloids Surf B Biointerfaces; 2015 Nov; 135():682-688. PubMed ID: 26340357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEG-PE/clay composite carriers for doxorubicin: Effect of composite structure on release, cell interaction and cytotoxicity.
    Kohay H; Sarisozen C; Sawant R; Jhaveri A; Torchilin VP; Mishael YG
    Acta Biomater; 2017 Jun; 55():443-454. PubMed ID: 28400314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
    Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
    Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy.
    Ma B; Zhuang W; Wang Y; Luo R; Wang Y
    Acta Biomater; 2018 Apr; 70():186-196. PubMed ID: 29452272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects.
    Lages EB; Fernandes RS; Andrade MMS; Paiyabhroma N; de Oliveira RB; Fernandes C; Cassali GD; Sicard P; Richard S; Branco de Barros AL; Ferreira LAM
    Biomed Pharmacother; 2021 Dec; 144():112373. PubMed ID: 34794238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.
    Rui M; Qu Y; Gao T; Ge Y; Feng C; Xu X
    Int J Nanomedicine; 2017; 12():217-237. PubMed ID: 28115844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pendant HDAC inhibitor SAHA derivatised polymer as a novel prodrug micellar carrier for anticancer drugs.
    Xu J; Sun J; Wang P; Ma X; Li S
    J Drug Target; 2018; 26(5-6):448-457. PubMed ID: 29251528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers.
    Huang X; Liao W; Xie Z; Chen D; Zhang CY
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():27-37. PubMed ID: 29853091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed nanomicelles as potential carriers for systemic delivery of Z-GP-Dox, an FAPα-based doxorubicin prodrug: formulation and pharmacokinetic evaluation.
    Zhang Y; Zhang X; Liu H; Cai S; Wu B
    Int J Nanomedicine; 2015; 10():1625-36. PubMed ID: 25759584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.